SLC5A2 and aortic stenosis: The median time to event for these outcomes was in excess of 3 years, so it may be appropriate to offer this ‘targeted’ group comprehensive programmes designed to improve risk factor profiles,9 as well as early initiation of therapeutics such as sodium-glucose cotransporter 2 inhibitors to reduce the risk of disease progression and cardiovascular morbidity.25–27 Furthermore, older persons identified for AF screening were more than twice as likely to be diagnosed with aortic stenosis as their lower-risk counterparts.